CHD5 immuno-localization was investigated in a total of 90 primary NTs (63 NB including 24 stage 4, 8 stage 4s and 31 loco-regional NB; 14 GNB and 13 GN) (Table 1). This evidence concerns the gene CHD5 and neuroblastoma.